Zomedica, Celsee Inc. partner to deliver cancer liquid biopsy platformDecember 21, 2017Zomedica Pharmaceuticals Corp. has entered into a license and supply agreement with Celsee Inc., an innovator of progressive rare cell capture, characterization, and retrieval products in the emerging field of liquid biopsy. Under the terms of the agreement, Zomedica will have animal health exclusive global rights to develop and market Celsee's liquid biopsy platform for use by veterinarians as a cancer diagnostic. A liquid biopsy is a blood test with the potential to detect the presence of circulating tumor cells in the blood. Circulating tumor cells (CTC) are shed from a primary tumor into neighboring blood vessels and are transported throughout the body's circulatory system. The detection of CTCs in the blood could indicate a cancer diagnosis without the need for an invasive tissue biopsy, according to Zomedica. "Liquid biopsy is cutting-edge technology in human medicine right now and we're excited about the opportunity to develop and market this platform for use in veterinary medicine," stated Gerald Solensky, Jr., CEO at Zomedica. "We selected the Celsee platform because of the ease of use, workflow simplicity, and flexibility to use our novel canine biomarkers. If we successfully develop Celsee's technology, we believe we will be able to …
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More
Nationwide supports National Pet Cancer Awareness Month through social mediaNovember 8, 2017November is National Pet Cancer Awareness Month, and Nationwide is partnering with the Animal Cancer Foundation to increase awareness and raise funds to fight the number one disease-related killer of dogs and cats. Last year, the company received more than 78,000 pet insurance claims for cancer diagnosis and treatment in pets, making cancer-related conditions one of the most common types of medical claims. In fact, last year members accumulated more than $23 million in medical expenses for pet cancer-related conditions. During the month of November, Nationwide will donate $5 to the Animal Cancer Foundation up to $50,000 for every photo, story, or statistic shared on Facebook, Twitter, and Instagram using #CurePetCancer (visit curepetcancer.com for more information). The 10 most common pet cancer-related claims, in order, received by Nationwide last year: Malignant skin neoplasia Lymohosarcoma Splenic neoplasia Hepatic neoplasia Bone or joint neoplasia Thoracic neoplasia Bladder neoplasia Anal sac neoplasia Malignant oral neoplasia Brain or spinal cord neoplasia
Researchers back comparative oncology to solve shared kid, dog cancersAugust 9, 2017Top cancer researchers and leaders in pediatric and veterinary medicine gathered for the first-ever Paws for a Cure Summit, hosted by Canines-N-Kids Foundation, a nonprofit that promotes research for the benefit of both kids and dogs with cancer, to discuss barriers and find solutions for enhancing collaborative efforts aimed at finding cures.
Dog noses as a diagnostic copilot?July 14, 2017It's no secret that dogs, through the wonders of their noses, can identify several types of cancers, including prostrate, breast, colon, lung, thyroid and ovarian cancers, and melanoma.
Zoo elephant undergoes successful cancer procedureJuly 6, 2017Joe Impellizeri, DVM, DACVIM (Oncology), MRCVS, of Veterinary Oncology Services of Middletown, N.Y., Lisa DiBernardi, DVM, ACVIM, ACVR, of Gulf Coast Veterinary Specialists in Houston, and the El Paso Zoo animal care team successfully performed electrochemotherapy on Juno, one of the zoo’s Asian elephants.
The latest in treating canine lymphomaJune 26, 2017Everybody reading this article has likely had their life touched by cancer, either personally or through a friend, family member or beloved pet. Cancer is something we all want eradicated.
The gonadectomy controversyJune 23, 2017One of the most controversial topics in the veterinary cancer field is the potential effect of gonadectomy on cancer risk. Spaying and neutering have obvious benefits with regard to population control and in preventing ovarian and testicular cancers.
UC Davis creates test for equine SCCJune 6, 2017There’s still no cure for Squamous cell carcinoma (SCC) in horses, but a new study from UC Davis can help detect horses at risk for it. SCC is one of the most common cancers that hits equines in their eyes, and the second most common tumor in horses, according to UC Davis.
Immunotherapy: The next best hope for defeating cancer?December 21, 2016Whether you’re treating something as deadly as cancer or as frustrating as chronic allergies, immunotherapy offers the possibility of slowing or reversing disease.
Collaboration comes together to study cancer in pets and humansNovember 11, 2016Can the study of cancer in dogs lead to new treatment options for humans? Scientists at the North Carolina State University College of Veterinary Medicine and the Duke Cancer Institute believe so and have entered into a collaboration designed to facilitate research projects aimed at benefiting both species.
